While for most cancers incidence and mortality are decreasing, those of non-Hodgkin's
lymphoma (NHL) are steadily increasing. Research to define reasons for this increase is …

The incidence of AIDS-defining cancers (ADCs)–Kaposi sarcoma, primary central nervous
system lymphoma, non-Hodgkin lymphoma, and cervical cancer–although on the decline …

Background Burkitt's lymphoma is an aggressive B-cell lymphoma that occurs in children
and adults and is largely curable with the use of intensive and toxic chemotherapy. Current …

Among the most common HIV-associated lymphomas are Burkitt lymphoma (BL) and diffuse
large B-cell lymphoma (DLBCL) with immunoblastic-plasmacytoid differentiation (also …

We assessed the cerebrospinal fluid (CSF) by flow cytometry and cytology in 51 newly
diagnosed and 9 treated aggressive B-cell lymphomas at risk for central nervous system …

The addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisone
(CHOP) chemotherapy results in significant improvement in clinical outcome for individuals …

Limited comparative data exist for the treatment of HIV-associated non-Hodgkin lymphoma.
We analyzed pooled individual patient data for 1546 patients from 19 prospective clinical …

Rituximab plus intravenous bolus chemotherapy is a standard treatment for
immunocompetent patients with B-cell non-Hodgkin lymphoma (NHL). Some studies have …

Over the past 10 years, significant progress has been made in understanding HIV-
associated lymphomas and improving the prognosis of these diseases. With the advent of …

A joint working group established by the Haemato‐oncology subgroup of the British
Committee for Standards in Haematology (BCSH) and the British Transplantation Society …